Seelos Therapeutics Valuation
| SEEL Stock | USD 0.33 0.06 15.38% |
Seelos Therapeutics seems to be undervalued based on Macroaxis valuation methodology. Our model measures the value of Seelos Therapeutics from inspecting the company fundamentals such as Return On Equity of -5.84, shares owned by insiders of 2.00 %, and Current Valuation of 16.5 M as well as reviewing its technical indicators and probability of bankruptcy. In general, most investors recommend picking up undervalued stocks and discarding overvalued stocks since, at some point, asset prices and their ongoing real values will draw towards each other. Key fundamental drivers impacting Seelos Therapeutics' valuation include:
Price Book 15.098 | Enterprise Value 16.5 M | Enterprise Value Ebitda (0.47) | Price Sales 2.8696 | Enterprise Value Revenue 220.4554 |
Undervalued
Today
Please note that Seelos Therapeutics' price fluctuation is out of control at this time. Calculation of the real value of Seelos Therapeutics is based on 3 months time horizon. Increasing Seelos Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Seelos Therapeutics is useful when determining the fair value of the Seelos stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Seelos Therapeutics. Since Seelos Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Seelos Stock. However, Seelos Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.33 | Real 0.87 | Target 2.5 | Hype 0.45 | Naive 0.48 |
The real value of Seelos Stock, also known as its intrinsic value, is the underlying worth of Seelos Therapeutics Company, which is reflected in its stock price. It is based on Seelos Therapeutics' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Seelos Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Seelos Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Seelos Therapeutics helps investors to forecast how Seelos stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Seelos Therapeutics more accurately as focusing exclusively on Seelos Therapeutics' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Seelos Therapeutics' intrinsic value based on its ongoing forecasts of Seelos Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Seelos Therapeutics' closest peers. When choosing an evaluation method for Seelos Therapeutics, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Seelos Valuation Trend
Knowing Seelos Therapeutics' actual value is paramount for traders to make sound investment determinations. Seelos Therapeutics' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Seelos Therapeutics' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Seelos Therapeutics' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Seelos Market Cap
Seelos Therapeutics is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is at this time estimated at about 25.77 Billion. Seelos Therapeutics adds roughly 5.27 Million in market capitalization claiming only tiny portion of equities under Health Care industry.Seelos Therapeutics Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Seelos Therapeutics's current stock value. Our valuation model uses many indicators to compare Seelos Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Seelos Therapeutics competition to find correlations between indicators driving Seelos Therapeutics's intrinsic value. More Info.Seelos Therapeutics is currently regarded as top stock in price to book category among related companies. It is rated fifth in price to sales category among related companies fabricating about 0.19 of Price To Sales per Price To Book. The ratio of Price To Book to Price To Sales for Seelos Therapeutics is roughly 5.26 . At this time, Seelos Therapeutics' Price To Sales Ratio is quite stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Seelos Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Seelos Therapeutics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Seelos Therapeutics' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Seelos Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Seelos Therapeutics and how it compares across the competition.
About Seelos Therapeutics Valuation
The stock valuation mechanism determines the current worth of Seelos Therapeutics on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Seelos Therapeutics. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Seelos Therapeutics based exclusively on its fundamental and basic technical indicators. By analyzing Seelos Therapeutics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Seelos Therapeutics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Seelos Therapeutics. We calculate exposure to Seelos Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Seelos Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.1 M | 2.3 M | |
| Pretax Profit Margin | (15.48) | (16.25) | |
| Operating Profit Margin | (16.55) | (17.37) | |
| Net Loss | (15.48) | (16.25) | |
| Gross Profit Margin | 1.12 | 1.18 |
8 Steps to conduct Seelos Therapeutics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Seelos Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Seelos Therapeutics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Seelos Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Seelos Therapeutics' revenue streams: Identify Seelos Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Seelos Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Seelos Therapeutics' growth potential: Evaluate Seelos Therapeutics' management, business model, and growth potential.
- Determine Seelos Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Seelos Therapeutics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Seelos Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Seelos Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 4.9 M |
Seelos Therapeutics Current Valuation Indicators
Valuation refers to the process of determining the present value of Seelos Therapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Seelos we look at many different elements of the entity such as Seelos's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Seelos Therapeutics' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Seelos Therapeutics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Seelos Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Seelos Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Seelos Therapeutics' worth.When determining whether Seelos Therapeutics is a strong investment it is important to analyze Seelos Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Seelos Therapeutics' future performance. For an informed investment choice regarding Seelos Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Seelos Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy Seelos Stock please use our How to buy in Seelos Stock guide.Note that the Seelos Therapeutics information on this page should be used as a complementary analysis to other Seelos Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Seelos Stock analysis
When running Seelos Therapeutics' price analysis, check to measure Seelos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seelos Therapeutics is operating at the current time. Most of Seelos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Seelos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seelos Therapeutics' price. Additionally, you may evaluate how the addition of Seelos Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is Seelos Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Seelos Therapeutics. If investors know Seelos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Seelos Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.73) | Revenue Per Share 0.45 | Return On Assets (1.80) | Return On Equity (5.84) |
The market value of Seelos Therapeutics is measured differently than its book value, which is the value of Seelos that is recorded on the company's balance sheet. Investors also form their own opinion of Seelos Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Seelos Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Seelos Therapeutics' market value can be influenced by many factors that don't directly affect Seelos Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Seelos Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Seelos Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Seelos Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.